From: Long-term clinical prognosis of 335 infant single-gene positive FEVR cases
Gene | Closed-V | LSV | PPV + Silicone oil/C3F8 | SB | Cryotherapy | IVR | Laser coagulation | Strabotomy | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eyes | Percentage | Eyes | Percentage | Eyes | Percentage | Eyes | Percentage | Eyes | Percentage | Eyes | Percentage | Eyes | Percentage | Eyes | Percentage | |
LRP5 (n = 190) | 22 | 11.6% | 6 | 3.2% | 9 | 4.7% | 2 | 1.1% | 1 | 0.5% | 15 | 7.9% | 17 | 8.9% | 1 | 0.5% |
FZD4 (n = 150) | 20 | 13.3% | 3 | 2.0% | 6 | 4.0% | 0 | 0.0% | 0 | 0.0% | 3 | 2.0% | 11 | 7.3% | 0 | 0.0% |
KIF11 (n = 118) | 19 | 16.1% | 0 | 0.0% | 3 | 2.5% | 2 | 1.7% | 0 | 0.0% | 3 | 2.5% | 2 | 1.7% | 2 | 1.7% |
NDP (n = 96) | 30 | 31.3% | 4 | 4.2% | 2 | 2.1% | 0 | 0.0% | 0 | 0.0% | 14 | 14.6% | 5 | 5.2% | 0 | 0.0% |
TSPAN12 (n = 92) | 6 | 6.5% | 1 | 1.1% | 1 | 1.1% | 0 | 0.0% | 1 | 1.1% | 6 | 6.5% | 4 | 4.3% | 1 | 1.1% |
ZNF408 (n = 24) | 4 | 16.7% | 0 | 0.0% | 1 | 4.2% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 2 | 8.3% | 0 | 0.0% |